Polymorphic repeats in the androgen receptor gene: Molecular markers of prostate cancer risk

Cancer Research

Volumn 57, Issue 6, 1997, Pages 1194-1198

  Stanford, Janet L ^a,b   Just, Jeanette J ^a,c   Gibbs, Mark ^a   Wicklund, Kristine G ^a   Neal, Cassandra L ^a   Blumenstein, Brent A ^a   Ostrander, Elaine A ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR;

ADULT; ARTICLE; BODY MASS; CANCER RISK; CONTROLLED STUDY; DIAGNOSTIC VALUE; DNA DETERMINATION; DNA POLYMORPHISM; GENETIC ASSOCIATION; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER;

ADENOCARCINOMA; ADULT; ANDROGENS; BODY MASS INDEX; CASE-CONTROL STUDIES; DISEASE PROGRESSION; DISEASE SUSCEPTIBILITY; DNA; DNA, NEOPLASM; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, HORMONE-DEPENDENT; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; RISK FACTORS; TRINUCLEOTIDE REPEATS; WASHINGTON;

EID: 0030890995     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Parker, S. L., Tong, T., Bolden, S., and Wingo, P. A. Cancer Statistics 1996. CA Cancer J. Clin., 23: 1996.
2. Monroe, K. R., Yu, M. C., Kolonel, L. N., Coetzee, G. A., Wilkens, L. R., Ross, R. K., and Henderson, B. E. Evidence of an X-linked or recessive genetic component to prostate cancer risk. Nat. Med., 1: 827-829, 1995.
3. Carter. B. S., Beaty, T. H., Steinberg, G. D., Childs, B., and Walsh, P. C. Mendelian inheritance of familial prostate cancer. Proc. Natl. Acad. Sci. USA, 89: 3367-3371, 1992.
4. Carter, B. S., Bova, G. S., Beaty, T. H., Steinberg, G. D., Childs, B., Isaacs, W. B., and Walsh, P. C. Hereditary prostate cancer: epidemiologic and clinical features. J. Urol., 150: 797-802, 1993.
5. Coetzee, G. A., and Ross, R. K. Prostate cancer and the androgen receptor. J. Natl. Cancer Inst., 86: 872-873, 1994.
6. Brown, T. R., Lubahn, D. B., Wilson, E. M., Joseph, D. R., French, F. S., and Migeon, C. J. Deletion of the steroid-binding domain of the human androgen receptor gene in one family with complete androgen insensitivity syndrome: evidence for further genetic heterogeneity in this syndrome. Proc. Natl. Acad. Sci., 85: 8151-8155, 1988.
7. Lubahn, D. B., Joseph, D. R., Sar, M., Tan, J., Higgs, H. N., Larson, R. E., French, F. S., and Wilson, E. M. The human androgen receptor: complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate. Mol. Endo-crinol., 2: 1265-1275, 1988.
8. Chang. C., Kokontis, J., and Liao, S. Molecular cloning of human and rat complementary DNA encoding androgen receptors. Science (Washington DC), 240: 324-326, 1988.
9. Veldscholte, J., Ris-Stalpers, C., Kuiper, G. G., Jenster, G., Berrovoets, C., Claasen, E., van Rooij, H. C., Trapman, J., Brinkmann, A. O., and Mulder. E. A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. Biochem. Biophys. Res. Commun., 173: 534-540, 1990.
10. Newmark, J. R., Hardy, D. O., Tonb, D. C., Carter, B. S., Epstein, J. I., Isaacs, W. B., Brown, T. R., and Barrack, E. R. Androgen Receptor gene mutations in human prostate cancer. Proc. Natl. Acad. Sci. USA, 89: 6319-6323, 1992.
11. Culig, Z., Hobisch, A., Cronauer, M. V., Cato, A. C. B., Hittmair, A., Radmayr. C., Eberle, J., Bartsch, G., and Klocker. H. Mutant androgen receptor detected in an advanced stage of prostatic carcinoma is activated by adrenal androgens and progesterone. Mol. Endocrinol., 7: 1541-1550, 1993.
12. Suzuki, H., Sato, N., Watabe, Y., Masai, M., Seino, S., and Shimazaki, J. Androgen receptor gene mutations in human prostate cancer. J. Steroid Biochem. Mol. Biol., 46: 759-765, 1993.
13. Gaddipati, J. P., McLeod, D. G., Heidenberg, H. B., Sesterhenn, I. A., Finger, M. J., Moul, J. W., and Srivastava, S. Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers. Cancer Res., 54: 2861-2864, 1994.
14. Taplin, M-E., Bubley, G. J., Shuster. T. D., Frantz, M. E., Spooner, A. E., Ogata, G. K., Keer, H. N., and Balk, S. P. Mutation of the androgen-receptor gene in metastatic androgen independent prostate cancer. N. Engl. J. Med., 332: 1393-1398, 1995.
15. Visakorpi, T., Hyytinen, E., Kolvisto, P., Tanner. M., Keinänen, R., Palmberg, C., Palotie, A., Tammela, T., Isola, J., and Kallioniemi. O-P. In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat. Genet., 9: 401-406, 1995.
16. Edwards, A., Hammond. H. A., Jin, L., Caskey, C. T., and Chakraborty, R. Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups. Genomics, 12: 241-253, 1992.
17. Sleddens, H. F., Oostra, B. A., Brinkmann. A. O., and Trapman, J. Trinucleotide (GGN) repeat polymorphism in the human androgen receptor (AR) gene. Hum. Mol. Genet., 2: 493, 1993.
18. Irvine, R. A., Yu, M. C., Ross, R. K., and Coetzee, G. A. The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res., 55: 1937-1940, 1995.
19. Ross, R. K., Coetzee, G. A., Reichardt, J., Skinner, E., and Henderson, B. E. Does the racial-ethnic variation in prostate cancer risk have a hormonal basis? Cancer (Phila.), 75: 1778-1782, 1995.
20. Schoenberg, M. P., Hakimi, J. M., Wang, S., Bova, G. S., Epstein. J. I., Fischbeck, K. H., Isaacs, W. B., Walsh. P. C., and Barrack, E. R. Microsatellite mutation (CAG-24-18) in the androgen receptor gene in human prostate cancer. Biochem. Biophys. Res. Commun., 198: 74-80, 1994.
21. Sun, S., Narod, S. A., Aprikian, A., Ghadirian, P., and Labrie, F. Androgen receptor and familial prostate cancer. Nat. Med., 1: 848-849, 1995.
22. La Spada, A. R., Wilson, E. M., Lubahn, D. B., Harding, A. E., and Fischbeck, K. H. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature (Lond.), 352: 77-79, 1991.
23. Mhatre, A. N., Trifiro, M. A., Kaufman, M., Kazemi-Esfarjani, P., Figlewicz, D., and Rouleau, G. Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy. Nat. Genet., 5: 184-188, 1993.
24. Chamberlain. N. L., Driver, E. D., and Miesfield, R. L. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect trans-activation function. Nucleic Acids Res., 22: 3181-3186, 1994.
25. Waksberg, J. Sample methods for random digit dialing. J. Am. Stat. Soc., 73: 40-46, 1978.
26. Harlow, B. L., and Davis, S. Two one-step methods for household screening and interviewing using random digit dialing. Am. J. Epidemiol., 127: 857-863, 1988.
27. The SEER Program Code Manual. Cancer Statistics Branch Surveillance Program, Division of Cancer Prevention and Control. National Cancer Institute, 1992.
28. Percy, C., Van Holten, V., and Muir, C. (eds.). International Classification of Diseases for Oncology, Ed. 2. Geneva, Switzerland: WHO, 1990.
29. Graham, S. D. J. Critical assessment of prostate cancer staging. Cancer (Phila.), 70: 269-274, 1992.
30. Breslow, N. E., and Day. N. E. The Analysis of Case-Control Studies. Lyon, France: IARC, 1980.